Rizwan Romee

9.3k total citations · 1 hit paper
135 papers, 3.7k citations indexed

About

Rizwan Romee is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Rizwan Romee has authored 135 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Hematology, 72 papers in Immunology and 48 papers in Oncology. Recurrent topics in Rizwan Romee's work include Hematopoietic Stem Cell Transplantation (73 papers), Immune Cell Function and Interaction (61 papers) and CAR-T cell therapy research (33 papers). Rizwan Romee is often cited by papers focused on Hematopoietic Stem Cell Transplantation (73 papers), Immune Cell Function and Interaction (61 papers) and CAR-T cell therapy research (33 papers). Rizwan Romee collaborates with scholars based in United States, Italy and Canada. Rizwan Romee's co-authors include Todd A. Fehniger, Jeffrey Leong, Megan A. Cooper, Ryan P. Sullivan, Stephanie Schneider, Julie Chase, Catherine R. Keppel, Melissa M. Berrien-Elliott, John F. DiPersio and Peter Westervelt and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Rizwan Romee

124 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia

2016 660 citations Rizwan Romee, Melissa M. Berrien-Elliott et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rizwan Romee United States	26	2.6k	1.8k	1.2k	392	311	135	3.7k
Harry Dolstra Netherlands	42	3.3k 1.3×	2.4k 1.4×	1.6k 1.4×	1.1k 2.8×	228 0.7×	123	5.2k
Alice Bertaina Italy	35	1.8k 0.7×	996 0.6×	1.5k 1.2×	628 1.6×	399 1.3×	141	3.6k
Marusca Capanni Italy	18	4.5k 1.7×	1.9k 1.1×	2.7k 2.3×	360 0.9×	409 1.3×	23	5.3k
Sarah Nikiforow United States	31	1.4k 0.5×	1.8k 1.0×	1.2k 1.0×	463 1.2×	509 1.6×	152	3.4k
Porunelloor A. Mathew United States	35	3.6k 1.4×	915 0.5×	1.2k 1.0×	475 1.2×	216 0.7×	76	4.4k
Adelmo Terenzi Italy	23	2.1k 0.8×	920 0.5×	2.6k 2.2×	265 0.7×	275 0.9×	64	3.5k
Alessandra Carotti Italy	21	2.3k 0.9×	997 0.6×	2.4k 2.0×	222 0.6×	666 2.1×	64	3.7k
Thierry Guillaume France	28	885 0.3×	879 0.5×	1.4k 1.2×	441 1.1×	385 1.2×	179	2.7k
Nicolas Dulphy France	31	2.2k 0.8×	545 0.3×	593 0.5×	264 0.7×	558 1.8×	69	2.9k
Markus Uhrberg Germany	33	3.8k 1.4×	632 0.4×	720 0.6×	417 1.1×	256 0.8×	78	4.3k

Countries citing papers authored by Rizwan Romee

Since Specialization

Citations

This map shows the geographic impact of Rizwan Romee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rizwan Romee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rizwan Romee more than expected).

Fields of papers citing papers by Rizwan Romee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rizwan Romee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rizwan Romee. The network helps show where Rizwan Romee may publish in the future.

Co-authorship network of co-authors of Rizwan Romee

This figure shows the co-authorship network connecting the top 25 collaborators of Rizwan Romee. A scholar is included among the top collaborators of Rizwan Romee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rizwan Romee. Rizwan Romee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Fuguo, Mubin Tarannum, Yingjie Zhao, et al.. (2025). Selective HLA knockdown and PD-L1 expression prevent allogeneic CAR-NK cell rejection and enhance safety and anti-tumor responses in xenograft mice. Nature Communications. 16(1). 8809–8809. 1 indexed citations

Kim, Haesook T., Vincent T. Ho, Sarah Nikiforow, et al.. (2024). Comparison of Older Related versus Younger Unrelated Donors for Older Recipients of Allogeneic Hematopoietic Cell Transplantation with Acute Myeloid Leukemia or Myelodysplastic Syndrome: A Large Single-Center Analysis. Transplantation and Cellular Therapy. 30(7). 687.e1–687.e13. 3 indexed citations

Tarannum, Mubin, Joana R. Lérias, Luís Miguel Borrego, et al.. (2024). Building a Better Defense: Expanding and Improving Natural Killer Cells for Adoptive Cell Therapy. Cells. 13(5). 451–451. 28 indexed citations

Ali, Alaa Kassim, et al.. (2024). An innovative single-cell approach for phenotyping and functional genotyping of CAR NK cells. Journal for ImmunoTherapy of Cancer. 12(5). e008912–e008912. 4 indexed citations

Shapiro, Roman M., Haesook T. Kim, Michela Ansuinelli, et al.. (2023). Cytokine release syndrome in haploidentical stem cell transplant may impact T-cell recovery and relapse. Blood Advances. 7(15). 4080–4088. 2 indexed citations

Choi, Jaebok, Matthew Cooper, Mark A. Fiala, et al.. (2023). Phase I-II Trial of Early Azacitidine after Matched Unrelated Donor Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. 29(11). 699.e1–699.e9. 2 indexed citations

Ikegawa, Shuntaro, Haesook T. Kim, Gordon J. Freeman, et al.. (2022). Low Dose IL-2 Therapy in Patients with Chronic Gvhd Induces PD-1+treg That Are Highly Activated, Immune Suppressive, and Proapoptotic. Transplantation and Cellular Therapy. 28(3). S59–S60. 1 indexed citations

Little, Jessica S, Roman M. Shapiro, David W. Kubiak, et al.. (2022). Invasive Yeast Infection after Haploidentical Donor Hematopoietic Cell Transplantation Associated with Cytokine Release Syndrome. Transplantation and Cellular Therapy. 28(8). 508.e1–508.e8. 8 indexed citations

Abboud, Ramzi, Fei Wan, Jacopo Mariotti, et al.. (2021). Cytokine release syndrome after haploidentical hematopoietic cell transplantation: an international multicenter analysis. Bone Marrow Transplantation. 56(11). 2763–2770. 25 indexed citations

10.

Maurer, Katie, Haesook T. Kim, Utkarsh Acharya, et al.. (2021). COVID-19 and hematopoietic stem cell transplantation and immune effector cell therapy: a US cancer center experience. Blood Advances. 5(3). 861–871. 24 indexed citations

11.

Chin, Kuo‐Kai, Haesook T. Kim, Vincent T. Ho, et al.. (2021). Ibrutinib in Steroid-Refractory Chronic Graft-versus-Host Disease, a Single-Center Experience. Transplantation and Cellular Therapy. 27(12). 990.e1–990.e7. 14 indexed citations

12.

Maurer, Katie, Haesook T. Kim, Carol Reynolds, et al.. (2021). Impact of cryopreservation and transit times of allogeneic grafts on hematopoietic and immune reconstitution. Blood Advances. 5(23). 5140–5149. 20 indexed citations

13.

Abedin, Sameem, Mark A. Schroeder, Rizwan Romee, et al.. (2021). Ruxolitinib resistance or intolerance in steroid‐refractory acute graft‐versus‐host disease — a real‐world outcomes analysis. British Journal of Haematology. 195(3). 429–432. 10 indexed citations

14.

Meybodi, Mohamad Aghaie, Wenhao Cao, Leo Luznik, et al.. (2019). HLA-haploidentical vs matched-sibling hematopoietic cell transplantation: a systematic review and meta-analysis. Blood Advances. 3(17). 2581–2585. 28 indexed citations

15.

Kim, Haesook T., Lindsey E. Roeker, Corey Cutler, et al.. (2019). Incidence, Predictors, and Outcomes of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 26(3). 529–539. 16 indexed citations

16.

Berrien-Elliott, Melissa M., Rizwan Romee, Julia A. Wagner, et al.. (2017). NKG2A Represents an Important Immune Checkpoint for Human Cytokine-Induced Memory-like NK Cells in Patients with AML. Blood. 130. 167–167. 2 indexed citations

17.

Ali, Alaa M., Feng Gao, Geoffrey L. Uy, et al.. (2017). Patterns of infectious complications in acute myeloid leukemia and myelodysplastic syndromes patients treated with 10‐day decitabine regimen. Cancer Medicine. 6(12). 2814–2821. 21 indexed citations

18.

Rashidi, Armin, Michael Slade, John F. DiPersio, et al.. (2016). Post-transplant high-dose cyclophosphamide after HLA-matched vs haploidentical hematopoietic cell transplantation for AML. Bone Marrow Transplantation. 51(12). 1561–1564. 25 indexed citations

19.

Rashidi, Armin, John F. DiPersio, Peter Westervelt, et al.. (2016). Peritransplant Serum Albumin Decline Predicts Subsequent Severe Acute Graft-versus-Host Disease after Mucotoxic Myeloablative Conditioning. Biology of Blood and Marrow Transplantation. 22(6). 1137–1141. 8 indexed citations

20.

Romee, Rizwan, Stephanie Schneider, Jeffrey Leong, et al.. (2012). Cytokine activation induces human memory-like NK cells. Blood. 120(24). 4751–4760. 491 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact